A New Treatment Era for Light-Chain Amyloidosis:Interprofessional Lessons From a Center of Excellence

1.00 hr(s) | ABIM , CME , CPE , MOC , NCPD

Therapeutic Area(s): Cardiology , Hematology, Benign , Oncology

Release Date: July 9, 2021

Expiration Date: July 8, 2022

Location: Internet Activity Enduring

In this activity, a panel of experts discusses a team-based approach to the management of light chain (AL) amyloidosis. Hear from Suzanne Lentzsch, MD, PhD, Mathew S. Maurer, MD, and Margaret Cuomo, MSN, FNP-C, from the Columbia University Medical Center, as they give insights on diagnostic strategies for AL amyloidosis and as they explore treatment guidelines, evidence, and safety concerns of established and novel approaches to managing AL amyloidosis.

Access this activity
Share via
Copy link
Powered by Social Snap